Dr. Geraldine Venthoye

Vice President

Pharmaceutical Development

Dr. Venthoye was appointed Vice President Pharmaceutical Development in February 2012, having joined the Company as Head of Inhalation Business Unit in September 2003. Previously, she had held senior CMC leadership and scientific roles in Inhale/Nektar Therapeutics, San Carlos, California, USA. Prior to this in the UK she held scientific positions in inhalation drug delivery at Vandsons Research and Norton Healthcare. Dr.Venthoye is a UK registered pharmacist and holds a doctorate degree in Pharmaceutics from the University of London. In 2011, Dr Venthoye was appointed Affiliate Assistant Professor in the Department of Pharmaceutics, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.